e-Pakiet dla mężczyzn — Men's Health Panel

Men-specific health screening with 17 biomarkers covering haematology, PSA for prostate screening, full lipid panel, liver enzymes, kidney function, uric acid, HbA1c, thyroid, inflammation, and vitamin D3. At 399 PLN (~92 EUR) with blood draw included. Addresses cardiovascular disease, metabolic syndrome, and prostate health — the leading modifiable health risks in men.

This panel targets the clinical priorities of men's health across cardiovascular, metabolic, and oncological domains. Prostate-specific antigen (PSA) is the primary screening biomarker for prostate cancer — the most commonly diagnosed non-skin malignancy in European men. Total PSA above 4.0 ng/mL traditionally triggers urological referral, though age-specific ranges improve clinical utility (2.5 ng/mL may warrant investigation in men under 50). The European Association of Urology recommends baseline PSA at age 40-45. PSA is organ-specific but not cancer-specific — benign prostatic hyperplasia, prostatitis, and recent ejaculation can all elevate values. Cardiovascular disease is the leading cause of death in European men. The full lipidogram enables SCORE2 risk calculation when combined with blood pressure and smoking history. HbA1c provides a 2-3 month glucose average, screening for type 2 diabetes and pre-diabetes — conditions substantially more prevalent in men than women at younger ages. The liver panel (AST, ALT) screens for hepatocellular damage. Men have higher rates of alcohol-related liver disease and NAFLD, making routine liver enzyme monitoring particularly relevant. Creatinine with eGFR assesses kidney function, while uric acid screens for hyperuricaemia — a risk factor for gout (which affects men 3-4 times more frequently than women) and an independent cardiovascular risk predictor. TSH provides thyroid screening. While thyroid disease is less prevalent in men, it remains underdiagnosed because symptoms (fatigue, weight gain, mood changes) are often attributed to other causes. Vitamin D3 assesses a nutrient where deficiency is endemic at northern European latitudes. The complete blood count screens for anaemia, infection, and blood disorders. CRP and ESR provide complementary inflammation measures. Fasting glucose adds an acute glycaemic assessment alongside the longer-term HbA1c window. At 399 PLN with blood draw included, this panel provides men's health coverage that would cost 400-700 EUR at a German private laboratory. The multi-buy discount (2nd package 269 PLN, 3rd 240 PLN) makes repeat testing for partners or family members particularly economical.